NASDAQ:PTGX
Protagonist Therapeutics, Inc.
- Stock
Last Close
31.94
17/05 20:00
Market Cap
1.80B
Beta: 1.95
Volume Today
437.12K
Avg: 1.73M
PE Ratio
−11.44
PFCF: −12.63
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.12 - | 0.22 80.95% | 0.00 99.33% | 0.09 5,817.06% | 0.08 10.82% | 0.11 36.26% | 0.17 56.34% | ||||
cash conversion cycle | -1.16K - | ||||||||||
cash per share | 1.58 - | 2.03 27.87% | 11.94 489.08% | 8.14 31.81% | 5.76 29.20% | 5.14 10.84% | 8.89 73.07% | 7.06 20.63% | 4.84 31.42% | 6.02 24.35% | |
company equity multiplier | 1.30 - | 1.55 19.16% | -1.46 194.06% | -1.61 10.81% | -0.99 38.42% | -0.71 28.32% | -1.14 60.63% | -0.85 25.71% | -0.46 45.62% | 1.06 330.18% | |
days of inventory outstanding | -1.14K - | ||||||||||
days of payables outstanding | 85.08 - | ||||||||||
days of sales outstanding | 57.54 - | 71.01 23.39% | 10.67K 14,931.95% | 44.75 99.58% | 58.14 29.93% | 0.71 98.77% | 62.85 8,702.40% | ||||
dividend yield | |||||||||||
ebit per revenue | -1.89 - | -1.37 27.64% | -348.58 25,402.63% | -2.25 99.35% | -4.60 104.12% | -4.94 7.44% | -1.56 68.42% | ||||
ebt per ebit | 1.19 - | 1.00 15.47% | 1.14 13.32% | 0.98 14.31% | 0.94 3.63% | 0.97 2.92% | 1.01 3.92% | 1.00 0.74% | 0.97 2.80% | 0.84 13.06% | |
effective tax rate | -0.16 - | -0.00 97.28% | -0.11 2,497.76% | 0.01 109.82% | 0.02 83.09% | 0.01 55.89% | -0.02 326.81% | 0.02 215.72% | 0.03 34.15% | 0.19 503.96% | |
enterprise value multiple | -8.16 - | -4.48 45.12% | -4.36 2.64% | -6.91 58.52% | -1.62 76.64% | -2.14 32.68% | -9.14 326.55% | -11.68 27.75% | -3.14 73.09% | -12.35 292.99% | |
fixed asset turnover | 22.82 - | 35.92 57.36% | 0.03 99.92% | 4.46 14,826.97% | 4.06 9.01% | 5.75 41.44% | 27.92 385.90% | ||||
free cash flow per share | -1.37 - | -2.51 83.83% | -4.67 85.82% | 0.18 103.88% | -2.26 1,344.60% | -1.64 27.23% | -2.12 29.24% | -2.35 10.91% | -2.22 5.57% | -1.25 43.81% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.94 5.52% | ||||
interest coverage | -476.46 - | -107.89 77.36% | 38.99 - | ||||||||
inventory turnover | -0.32 - | ||||||||||
long term debt to capitalization | -0.08 - | -0.02 79.35% | -0.01 44.04% | -0.00 76.37% | |||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 0.98 2.01% | 0.99 1.15% | 1.02 2.93% | 0.98 4.26% | 0.97 0.81% | 1 3.22% | |
net profit margin | -1.84 - | -1.26 31.67% | -334.14 26,447.55% | -2.31 99.31% | -4.48 93.99% | -4.64 3.58% | -1.32 71.66% | ||||
operating cash flow per share | -1.32 - | -2.44 85.78% | -4.61 88.59% | 0.22 104.75% | -2.23 1,120.59% | -1.60 28.19% | -2.11 31.40% | -2.33 10.50% | -2.20 5.31% | -1.24 43.88% | |
operating cycle | -1.08K - | ||||||||||
operating profit margin | -1.89 - | -1.37 27.64% | -348.58 25,402.63% | -2.25 99.35% | -4.60 104.12% | -4.94 7.44% | -1.56 68.42% | ||||
payables turnover | 4.29 - | ||||||||||
pretax profit margin | -1.84 - | -1.28 30.27% | -337.13 26,146.44% | -2.27 99.33% | -4.59 102.61% | -4.79 4.43% | -1.32 72.54% | ||||
price fair value | 8.66 - | 7.18 17.10% | -2.21 130.85% | -3.62 63.74% | -1.07 70.44% | -0.84 21.72% | -2.44 191.32% | -3.87 58.39% | -1.00 74.24% | 3.87 487.83% | |
receivables turnover | 6.34 - | 5.14 18.96% | 0.03 99.33% | 8.16 23,750.49% | 6.28 23.03% | 511.17 8,043.04% | 5.81 98.86% | ||||
return on assets | -1.07 - | -1.00 6.64% | -0.40 60.48% | -0.23 42.94% | -0.28 23.64% | -0.50 78.53% | -0.20 59.08% | -0.35 72.99% | -0.50 41.14% | -0.22 55.69% | |
return on capital employed | -1.04 - | -1.26 21.62% | -0.37 70.45% | -0.31 16.18% | -0.37 19.28% | -0.67 80.62% | -0.23 66.31% | -0.41 82.57% | -0.61 46.26% | -0.28 54.11% | |
return on equity | -1.39 - | -1.55 11.25% | 0.58 137.17% | 0.36 36.77% | 0.28 23.86% | 0.35 27.98% | 0.23 34.27% | 0.30 28.52% | 0.23 23.25% | -0.23 202.00% | |
total debt to capitalization | -0.01 - | -0.08 1,013.98% | -0.02 74.70% | -0.01 32.31% | -0.01 52.76% | 0.00 149.25% |
All numbers in USD (except ratios and percentages)